Healthcare: Thrombosis Research Trust drafts in advisers

The Thrombosis Research Trust has called in a brace of external PR advisers to help it build awareness of the work of its Thrombosis Research Institute (TRI) in the treatment and prevention of deep-vein thrombosis (DVT).

Chime-backed healthcare marketing outfit Ozone is working alongside strategic comms specialist The McDonough Partnership to highlight the work of the Chelsea-based TRI, particularly its founding director, professor Vijay Kakkar.

More than 500 hospital patients each week are dying from blood clots that could be prevented with cheap drugs, according to

a Commons Health Select Committee report that made front-page headlines last week.

Ozone wants to use documentaries and features to raise TRI's profile, while also working with DVT opinion leaders.

The agency will also promote several pieces of research to be released in the year ahead.

Media work will be focused around the 20th Congress of the International Society on Thrombosis & Haemostasis in Sydney in August.

Ozone MD Paul Jarman said PR work aimed to boost awareness among health professionals and the public of the dangers of, and how to prevent, thrombosis.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.